WMSA
GBT

Weiss Multi-Strategy Advisers’s Global Blood Therapeutics, Inc. GBT Stock Holding History

Weiss Multi-Strategy Advisers’s Portfolio GBT Stock Details GBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-66,052
Closed -$4.5M – 818
2022
Q3 		$4.5M Buy
66,052
+16,052
+32% +$885K 0.12% 260
2022
Q2 		$1.6M Buy
50,000
+42,000
+525% +$1.23M 0.05% 424
2022
Q1 		$277K Sell
8,000
-17,414
-69% -$521K 0.01% 609
2021
Q4 		$744K Sell
25,414
-104
-0.4% -$3.22K 0.02% 510
2021
Q3 		$650K Buy
25,518
+3,518
+16% +$103K 0.01% 530
2021
Q2 		$770K Buy
22,000
+5,927
+37% +$231K 0.02% 518
2021
Q1 		$655K Sell
16,073
-5,593
-26% -$257K 0.01% 529
2020
Q4 		$938K Sell
21,666
-10,334
-32% -$510K 0.02% 497
2020
Q3 		$1.76M Buy
32,000
+4,866
+18% +$309K 0.05% 365
2020
Q2 		$1.71M Buy
27,134
+718
+3% +$49.2K 0.05% 352
2020
Q1 		$1.35M Buy
26,416
+11,416
+76% +$765K 0.05% 279
2019
Q4 		$1.19M Buy
15,000
+5,000
+50% +$296K 0.02% 470
2019
Q3 		$485K Sell
10,000
-5,000
-33% -$261K 0.01% 495
2019
Q2 		$789K Buy
+15,000
New +$862K 0.02% 394
2018
Q3 		– Sell
-10,000
Closed -$452K – 697
2018
Q2 		$452K Sell
10,000
-8,750
-47% -$398K 0.01% 492
2018
Q1 		$906K Buy
18,750
+8,750
+88% +$488K 0.03% 428
2017
Q4 		$394K Buy
+10,000
New +$373K 0.01% 509

Other funds holding GBT

BTI
Blue Trust Inc Alpharetta, Georgia $8.74B AUM 14.62% 1-Year Est. Return
HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Weiss Multi-Strategy Advisers's GBT Position: Q4 2022 in Review

Weiss Multi-Strategy Advisers sold out of Global Blood Therapeutics, Inc. (GBT) in Q4 2022, closing a stake of 66,052 shares — an estimated $4.5M sold.

Weiss Multi-Strategy Advisers first reported a position in GBT in Q4 2017 and held it in 17 quarters. The position peaked at $4.5M in Q3 2022. 2 funds tracked by Wall St. Rank hold GBT as of Q4 2022.

  • Weiss Multi-Strategy Advisers reported no remaining Global Blood Therapeutics, Inc. position as of Q4 2022 after selling out during the quarter.
  • Weiss Multi-Strategy Advisers sold 66,052 Global Blood Therapeutics, Inc. shares in Q4 2022, an estimated $4.5M.
  • Weiss Multi-Strategy Advisers first reported a position in Global Blood Therapeutics, Inc. in Q4 2017 and held it in 17 quarters.
  • Weiss Multi-Strategy Advisers's Global Blood Therapeutics, Inc. position peaked at $4.5M in Q3 2022.
  • 2 funds tracked by Wall St. Rank held Global Blood Therapeutics, Inc. as of Q4 2022.

Based on Weiss Multi-Strategy Advisers's 13F filing for Q4 2022, filed 14 Feb 2023.